Loading institutional data...
Loading institutional data...
Held by 391 of 2,417 reporting institutions (98th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 27% of free cash flow, leaving room to grow it and fund buybacks. Last year: $701.0M dividends + $1.61B buybacks = $2.31B returned on $2.58B FCF.
9 consecutive years of dividend increases · 11%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 22%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $2.38B (at 2025-12-31) covers all $2.32B of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2026-09-30 (10-Q). The cash figure is from 2025-12-31, so the two are not the same balance-sheet date — the schedule has not been refiled since.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash of $2.38B fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $493.91 today, the market must believe free cash flow compounds 15.4%/yr for a decade (off $2.33B on the 3-yr avg basis).
On the basis ($2.11B) the requirement is 16.7%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 15.4% is more optimistic than its 9-yr track record.
Default is 9.4% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.17B shares (market data) · net debt $4.61B
mean 17.6% · volatility σ 46% · implied rate exceeded in 5/9 yrs
Central path = implied 15.4%/yr growth; shaded band = ±1σ (46%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 39 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| UBER | $134.3B | 13.9× | 21.9× | 2.6× | 18.3% | — | 19.3% | 37.2% | 26.8% | 0.5× | 714 |
| SPGI | $133.5B | 31.4× | 18.9× | 8.7× | 7.9% | 70.2% | 29.2% | 14.4% | 10.1% | 1.5× | 593 |
| SNOW | $116.5B | — | — | 24.9× | 29.2% | 67.2% | -28.4% | -69.2% | -69.2% | — | 464 |
| NOW | $113.4B | 65.7× | 43.4× | 8.5× | 20.9% | 77.5% | 13.2% | 13.5% | 12.1% | -0.9× | 745 |
| ADP | $113.2B | 26.1× | — | 5.2× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 822 |
| PDD | $112.8B | 33.6× | 7.3× | 1.8× | 14.5% | 56.3% | 22.7% | 23.7% | 23.7% | -1.2× | 82 |
| NET | $110.5B | — | — | 51.0× | 29.8% | 74.5% | -4.7% | -7.0% | -7.0% | — | 390 |
| ABNB | $98.1B | — | 36.5× | 8.0× | 10.3% | 83.0% | 20.5% | 30.6% | 24.6% | -1.8× | 364 |
| ADBE | $96.6B | 14.9× | 10.2× | 4.1× | 10.5% | 89.3% | 30.0% | 61.3% | 40.0% | 0.1× | 627 |
| DDOG | $95.5B | — | — | 27.9× | 27.7% | 80.0% | 3.1% | 2.9% | 2.9% | — | 350 |
| CDNS | $94.0B | 84.4× | 52.9× | 17.8× | 14.1% | — | 20.9% | 20.3% | 20.3% | -1.8× | 390 |
| SNPS | $93.9B | 61.0× | 66.4× | 13.3× | 15.1% | 77.0% | 18.9% | 4.7% | 3.2% | 6.7× | 389 |
| INTU | $88.5B | 20.1× | 15.1× | 4.1× | 13.9% | — | 21.3% | 24.0% | 17.1% | 0.5× | 532 |
| APP | $85.6B | 26.1× | 19.9× | 15.6× | 70.0% | 87.9% | 60.8% | 156% | 59.0% | 0.2× | 327 |
| MCO | $84.3B | 35.8× | — | 10.9× | 8.9% | 74.4% | 31.9% | 60.7% | 22.3% | — | 391 |
| MELI | $84.2B | 42.1× | — | 2.9× | 39.1% | 44.5% | 6.9% | 29.6% | 12.5% | — | 406 |
| DASH | $77.6B | 84.0× | 49.8× | 5.7× | 27.9% | — | 6.8% | 9.3% | 9.3% | -3.0× | 277 |
| URI | $74.2B | 31.1× | — | 4.6× | 4.9% | 38.2% | 15.5% | 27.8% | 10.0% | — | 506 |
| NTES | $71.8B | 74.7× | 11.9× | 4.5× | 11.6% | 64.3% | 30.9% | 21.7% | 21.7% | -1.2× | 101 |
| EBAY | $53.9B | 27.9× | 19.6× | 4.9× | 7.9% | 71.5% | 18.3% | 45.3% | 38.8% | -0.4× | 360 |
| EA | $52.9B | 59.7× | 36.3× | 7.0× | 0.9% | 79.0% | 11.8% | 13.1% | 13.1% | -2.1× | 2 |
| ADSK | $50.5B | 46.2× | 31.3× | 7.0× | 17.5% | 91.0% | 15.6% | 36.9% | 20.3% | 0.1× | 339 |
| VEEV | $50.2B | 57.0× | — | 15.7× | 16.3% | 75.5% | 28.4% | 12.6% | 12.6% | — | 342 |
| PYPL | $47.3B | 10.5× | 7.0× | 1.4× | 4.3% | — | 15.8% | 25.8% | 17.3% | 0.3× | 408 |
| WDAY | $47.1B | 75.5× | 50.7× | 4.9× | 13.1% | — | 7.3% | 8.9% | 6.4% | 1.6× | 262 |
Peers = companies sharing MCO's sector (Services-Consumer Credit Reporting, Collection Agencies) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.72B 100.0% | $7.09B 100.0% | $5.92B 100.0% | $5.47B 100.0% | $6.22B 100.0% | $5.37B 100.0% | $4.83B 100.0% | $4.44B 100.0% | $4.20B 100.0% | $3.60B 100.0% |
| Cost of Revenue | $1.97B 25.6% | $1.95B 27.4% | $1.69B 28.5% | $1.61B 29.5% | $1.64B 26.3% | $1.48B 27.5% | $1.39B 28.7% | $1.25B 28.0% | $1.22B 28.9% | — |
| Research & Development | — | — | — | — | — | — | — | $51.1M 1.2% | $42.0M 1.0% | $40.1M 1.1% |
| Selling, General & Admin | $1.80B 23.4% | $1.74B 24.5% | $1.63B 27.6% | $1.53B 27.9% | $1.48B 23.8% | $1.23B 22.9% | $1.17B 24.2% | $1.08B 24.3% | $986.0M 23.5% | $931.2M 25.8% |
| Total Operating Expenses | $4.37B 56.6% | $4.21B 59.4% | $3.78B 63.9% | $3.58B 65.6% | $3.37B 54.3% | $2.98B 55.5% | $2.83B 58.6% | $2.58B 58.0% | $2.38B 56.7% | $2.95B 81.9% |
| Operating Income | $3.35B 43.4% | $2.88B 40.6% | $2.14B 36.1% | $1.88B 34.4% | $2.84B 45.7% | $2.39B 44.5% | $2.00B 41.4% | $1.87B 42.0% | $1.82B 43.3% | $650.9M 18.1% |
| Interest & Investment Income | — | — | — | — | — | — | $17.0M 0.4% | $15.0M 0.3% | $16.0M 0.4% | $10.9M 0.3% |
| Other Income (Expense), net | -$221.0M -2.9% | -$176.0M -2.5% | -$202.0M -3.4% | -$123.0M -2.2% | -$89.0M -1.4% | -$159.0M -3.0% | -$188.0M -3.9% | -$196.0M -4.4% | -$34.0M -0.8% | -$92.9M -2.6% |
| Pretax Income | $3.13B 40.6% | $2.70B 38.1% | $1.94B 32.7% | $1.76B 32.2% | $2.75B 44.3% | $2.23B 41.5% | $1.81B 37.5% | $1.67B 37.6% | $1.79B 42.5% | $558.0M 15.5% |
| Income Tax Expense | $668.0M 8.7% | $640.0M 9.0% | $327.0M 5.5% | $386.0M 7.1% | $541.0M 8.7% | $452.0M 8.4% | $381.0M 7.9% | $352.0M 7.9% | $779.0M 18.5% | $282.2M 7.8% |
| Net Income | $2.46B 31.9% | $2.06B 29.0% | $1.61B 27.2% | $1.37B 25.1% | $2.21B 35.6% | $1.78B 33.1% | $1.42B 29.4% | $1.31B 29.5% | $1.00B 23.8% | $266.6M 7.4% |
| Per Share | ||||||||||
| EPS (Basic) | $13.73 | $11.32 | $8.77 | $7.47 | $11.88 | $9.48 | $7.51 | $6.84 | $5.24 | $1.38 |
| EPS (Diluted) | $13.67 | $11.26 | $8.73 | $7.44 | $11.78 | $9.39 | $7.42 | $6.74 | $5.15 | $1.36 |
| Weighted Avg Shares (Basic) | 179.1M | 181.8M | 183.2M | 183.9M | 186.4M | 187.6M | 189.3M | 191.6M | 191.1M | 192.7M |
| Weighted Avg Shares (Diluted) | 179.9M | 182.7M | 184.0M | 184.7M | 187.9M | 189.3M | 191.6M | 194.4M | 194.2M | 195.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 54th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 61% against ROIC 22% — 38% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 64.5% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 28.0 | 28.7 | 27.5 | 26.3 | 29.5 | 28.5 | 27.4 | 25.6 |
| R&D | 1.2 | — | — | — | — | — | — | — |
| SG&A | 24.3 | 24.2 | 22.9 | 23.8 | 27.9 | 27.6 | 24.5 | 23.4 |
| Operating Income | 42.0 | 41.4 | 44.5 | 45.7 | 34.4 | 36.1 | 40.6 | 43.4 |
| Income Tax | 7.9 | 7.9 | 8.4 | 8.7 | 7.1 | 5.5 | 9.0 | 8.7 |
| Net Income | 29.5 | 29.4 | 33.1 | 35.6 | 25.1 | 27.2 | 29.0 | 31.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MCO: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns 19.39pts above its cost of capital, positive in 5 of the last 5 years.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 31.5% | 9.4% (today's — no rate published for this year) | 22.1pts |
| FY2020 | 31.5% | 9.4% (today's — no rate published for this year) | 22.0pts |
| FY2021 | 25.0% | 9.4% (today's — no rate published for this year) | 15.6pts |
| FY2022 | 17.1% | 9.4% (today's — no rate published for this year) | 7.7pts |
| FY2023 | 19.4% | 9.4% (today's — no rate published for this year) | 10.0pts |
| FY2024 | 25.2% | 9.4% (today's — no rate published for this year) | 15.8pts |
| FY2025 | 29.0% | 9.4% (today's — no rate published for this year) | 19.5pts |
| Now | 22.3% | 9.4% | 12.8pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | 18.1% | 7.4% |
| FY2017 | 71.1% | 43.3% | 23.8% |
| FY2018 | 72.0% | 42.0% | 29.5% |
| FY2019 | 71.3% | 41.4% | 29.4% |
| FY2020 | 72.5% | 44.5% | 33.1% |
| FY2021 | 73.7% | 45.7% | 35.6% |
| FY2022 | 70.5% | 34.4% | 25.1% |
| FY2023 | 71.5% | 36.1% | 27.2% |
| FY2024 | 72.6% | 40.6% | 29.0% |
| FY2025 | 74.4% | 43.4% | 31.9% |
Leverage and buybacks account for 38 points of the 61% return on equity in FY2025. The business earns 22% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$6.3B of goodwill — 68% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer. With goodwill over half the base, the ex-goodwill figure divides by a small remainder and moves sharply — read it as a direction, not a precise rate.
ROIC ex-goodwill is 91.21% against 28.84% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Converts 1.03x of reported profit into cash — adequate, without much margin.
No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
Ladder as of 2026-09-30 (10-Q); cash from the 2025-12-31 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: ebitda, interest_expense.
At $488.83, free cash flow must compound 15.33%/yr for 10 years. It has done 8.19%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 27.2% | 15.3% |
| FY2021 | −8.7% | 15.3% |
| FY2022 | −36.2% | 15.3% |
| FY2023 | 57.9% | 15.3% |
| FY2024 | 34.1% | 15.3% |
| FY2025 | 2.1% | 15.3% |
The implied rate has been matched or beaten in 3 of the last 6 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $2.46B | $2.46B |
| Share-based comp | $232M | $2.69B |
| Other non-cash & working capital | $210M | $2.90B |
| Operating cash flow | $2.90B | $2.90B |
| Capex | −$326M | $2.58B |
| Free cash flow | $2.58B | $2.58B |
| FCF after SBC | $2.34B | $2.34B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 11.2% | 0.8% | -10.4 points |
| FY2021 | 15.8% | 20.3% | 4.5 points |
| FY2022 | -12.1% | -4.0% | 8.1 points |
| FY2023 | 8.2% | 0.4% | -7.8 points |
| FY2024 | 19.8% | 8.6% | -11.2 points |
| FY2025 | 8.9% | 12.4% | 3.5 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 107.3 days | not reported | 10 days | 97.3 days |
| FY2020 | 97.2 days | not reported | 9.7 days | 87.5 days |
| FY2021 | 101 days | not reported | 10.5 days | 90.5 days |
| FY2022 | 110.3 days | not reported | 11.8 days | 98.5 days |
| FY2023 | 102.4 days | not reported | 5 days | 97.4 days |
| FY2024 | 92.7 days | not reported | 9.9 days | 82.8 days |
| FY2025 | 95.7 days | not reported | 11.5 days | 84.2 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -2.5 percent |
| FY2020 | -3.0 percent |
| FY2021 | 1.4 percent |
| FY2022 | -0.7 percent |
| FY2023 | -3.7 percent |
| FY2024 | -5.0 percent |
| FY2025 | -2.8 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-29 | 7 co-filers CEO - Moody's Ratings | Exercise & sell | 200 | $486.52 | $97k |
| 2026-10-29 | 7 co-filers CEO - Moody's Ratings | Option exercise | 2,926 | $372.16 | $1.1m |
| 2026-10-29 | 7 co-filers CEO - Moody's Ratings | Exercise & sell | 2,926 | $488.14 | $1.4m |
| 2026-10-29 | 7 co-filers CEO - Moody's Ratings | Option exercise |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 6,820 |
| $372.16 |
| $2.5m |
| 2026-10-29 | 7 co-filers CEO - Moody's Ratings | Exercise & sell | 6,820 | $487.99 | $3.3m |
| 2026-10-29 | 7 co-filers CEO - Moody's Ratings | Option exercise | 2,926 | $0.00 | — |
| 2026-10-29 | 7 co-filers CEO - Moody's Ratings | Option exercise | 6,820 | $0.00 | — |
| 2026-10-01 | Minaya Jose Director | Grant | 92 | $447.36 | — |
| 2026-10-01 | 6 co-filers President and CEO | 10b5-1 plan sale | 300 | $455.00 | $137k |
| 2026-10-01 | Phillips Jason D Chief Acctg Off & Controller | Tax withholding | 21 | $450.80 | $10k |
| 2026-10-01 | 6 co-filers President and CEO | Option exercise | 51 | $113.34 | $6k |
| 2026-10-01 | 6 co-filers President and CEO | Option exercise | 572 | $167.50 | $96k |
| 2026-10-01 | 6 co-filers President and CEO | 10b5-1 plan sale | 623 | $455.00 | $283k |
| 2026-10-01 | 6 co-filers President and CEO | Option exercise | 51 | $0.00 | — |
| 2026-10-01 | 6 co-filers President and CEO | Option exercise | 572 | $0.00 | — |
| 2026-09-04 | 2 co-filers Group filing | Grant | 15 | $0.00 | $0 |
| 2026-09-04 | 2 co-filers Group filing | Grant | 7 | $0.00 | $0 |
| 2026-09-04 | 2 co-filers Group filing | Grant | 6 | $0.00 | $0 |
| 2026-09-04 | Esperdy Therese Director | Grant | 11 | $0.00 | $0 |
| 2026-09-04 | Sawicki Lisa P Director | Grant | 1 | $0.00 | $0 |
| 2026-09-04 | 2 co-filers Group filing | Grant | 14 | $0.00 | $0 |
| 2026-09-04 | 2 co-filers Group filing | Grant | 16 | $0.00 | $0 |
| 2026-09-04 | 2 co-filers Group filing | Grant | 3 | $493.55 | — |
| 2026-09-04 | 2 co-filers Group filing | Grant | 1 | $493.55 | — |
| 2026-09-04 | 2 co-filers Group filing | Grant | 2 | $0.00 | $0 |
| 2026-09-04 | 2 co-filers Group filing | Grant | 13 | $0.00 | $0 |
| 2026-09-04 | 2 co-filers Group filing | Grant | 1 | $0.00 | $0 |
| 2026-09-01 | 6 co-filers President and CEO | 10b5-1 plan sale | 300 | $501.89 | $151k |
| 2026-09-01 | 6 co-filers President and CEO | Option exercise | 592 | $113.34 | $67k |
| 2026-09-01 | 6 co-filers President and CEO | Option exercise | 575 | $167.50 | $96k |
| 2026-09-01 | 6 co-filers President and CEO | 10b5-1 plan sale | 1,167 | $501.89 | $586k |
| 2026-09-01 | 6 co-filers President and CEO | Option exercise | 592 | $0.00 | — |
| 2026-09-01 | 6 co-filers President and CEO | Option exercise | 575 | $0.00 | — |
| 2026-08-03 | 6 co-filers President and CEO | 10b5-1 plan sale | 300 | $484.30 | $145k |
| 2026-08-03 | 6 co-filers President and CEO | Option exercise | 592 | $113.34 | $67k |
| 2026-08-03 | 6 co-filers President and CEO | Option exercise | 575 | $167.50 | $96k |
| 2026-08-03 | 6 co-filers President and CEO | 10b5-1 plan sale | 1,167 | $484.30 | $565k |
| 2026-08-03 | 6 co-filers President and CEO | Option exercise | 592 | $0.00 | — |
| 2026-08-03 | 6 co-filers President and CEO | Option exercise | 575 | $0.00 | — |
| 2026-07-01 | Minaya Jose Director | Grant | 88 | $468.38 | — |